A novel remote intervention to decelerate the age-related decline and disease development among older breast cancer survivors

一种新型远程干预措施,可减缓老年乳腺癌幸存者与年龄相关的衰退和疾病发展

基本信息

  • 批准号:
    473462
  • 负责人:
  • 金额:
    $ 7.29万
  • 依托单位:
  • 依托单位国家:
    加拿大
  • 项目类别:
    Operating Grants
  • 财政年份:
    2022
  • 资助国家:
    加拿大
  • 起止时间:
    2022-09-01 至 2023-09-01
  • 项目状态:
    已结题

项目摘要

Five percent of Canadian women over age 65 have a history of breast cancer (BC) diagnosed within the last 15 years. Compared to 40 years ago, they are now much less likely to die from BC but more likely to die from cardiovascular (CVD), liver and Alzheime
65岁以上的加拿大女性中有5%在过去15年内被诊断出患有乳腺癌(BC)。与40年前相比,他们现在死于BC的可能性要小得多,但死于心血管(CVD)、肝脏和阿尔茨海默病的可能性要大得多

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kirkham Amy A其他文献

Kirkham Amy A的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kirkham Amy A', 18)}}的其他基金

A novel remote intervention to decelerate the age-related decline and disease development among older breast cancer survivors
一种新型远程干预措施,可减缓老年乳腺癌幸存者与年龄相关的衰退和疾病发展
  • 批准号:
    478415
  • 财政年份:
    2023
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Operating Grants
Beyond Cardiotoxicity: Characterizing the Short and Long-term Cardiovascular Side Effects of Breast Cancer Endocrine Treatment
超越心脏毒性:描述乳腺癌内分泌治疗的短期和长期心血管副作用
  • 批准号:
    488204
  • 财政年份:
    2023
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Operating Grants
Quantifying the cardiovascular and metabolic health benefits of Canada's physical activity and dietary guidelines in pre and postmenopausal women
量化加拿大体力活动和饮食指南对绝经前和绝经后女性心血管和代谢健康的益处
  • 批准号:
    478287
  • 财政年份:
    2023
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Operating Grants
Quantifying the cardiovascular and metabolic health benefits of Canada's physical activity and healthful eating guidelines on pre and postmenopausal women
量化加拿大体力活动和健康饮食指南对绝经前和绝经后妇女的心血管和代谢健康的益处
  • 批准号:
    473453
  • 财政年份:
    2022
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Operating Grants
Proof-of-concept of time-restricted eating as a novel lifestyle intervention for breast cancer prevention
限时饮食作为预防乳腺癌的新型生活方式干预措施的概念验证
  • 批准号:
    460504
  • 财政年份:
    2021
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Operating Grants
Exercise as supportive care has selective benefits for chemotherapy tolerance and weight gain
运动作为支持性护理对化疗耐受性和体重增加具有选择性益处
  • 批准号:
    400281
  • 财政年份:
    2019
  • 资助金额:
    $ 7.29万
  • 项目类别:
The Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study
热量限制和运动保护免受蒽环类药物毒性作用 (CREATE) 研究
  • 批准号:
    392372
  • 财政年份:
    2018
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Fellowship Programs
Magnetic Resonance Imaging Quantification of the Toxic Effects of Chemotherapy and Protective Effects of Lifestyle Intervention on Cardiovascular and Skeletal Muscle Function in Breast Cancer
磁共振成像量化乳腺癌化疗的毒性作用和生活方式干预对心血管和骨骼肌功能的保护作用
  • 批准号:
    319146
  • 财政年份:
    2014
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Fellowship Programs
Echocardiography Apprenticeship with Dr. Rob Shave
Rob Shave 博士的超声心动图学徒期
  • 批准号:
    314101
  • 财政年份:
    2014
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Miscellaneous Programs
Exercise Prescription in Breast Cancer Patients Undergoing Chemotherapy Treatment
接受化疗的乳腺癌患者的运动处方
  • 批准号:
    183184
  • 财政年份:
    2009
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Studentship Programs

相似海外基金

Intelligent Breast Cancer DiagnOsis and MonItoring Therapeutic Response Training Network (CanDoIt)
智能乳腺癌诊断和监测治疗反应训练网络(CanDoIt)
  • 批准号:
    EP/Y03693X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Research Grant
From single-cell transcriptomic to single-cell fluxomic: characterising metabolic dysregulations for breast cancer subtype classification
从单细胞转录组到单细胞通量组:表征乳腺癌亚型分类的代谢失调
  • 批准号:
    EP/Y001613/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Research Grant
Preclinical validation of synthetic biomolecules to treat Breast Cancer from AI-enabled discovery of novel lncRNA therapeutic targets.
通过人工智能发现新型 lncRNA 治疗靶点,对合成生物分子治疗乳腺癌进行临床前验证。
  • 批准号:
    10110204
  • 财政年份:
    2024
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Launchpad
Quad negative breast cancerに対する新たなプレシジョン・メディシン治療戦略
四阴性乳腺癌精准医学治疗新策略
  • 批准号:
    24K11748
  • 财政年份:
    2024
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ESR1 mutation profiling identifies potential drivers of metastatic breast cancer
ESR1 突变分析确定了转移性乳腺癌的潜在驱动因素
  • 批准号:
    MR/X018199/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Research Grant
Spatial-BrTME: Multicellular spatial dynamics of immunotherapy response in breast cancer
Spatial-BrTME:乳腺癌免疫治疗反应的多细胞空间动力学
  • 批准号:
    EP/Y014995/1
  • 财政年份:
    2024
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Research Grant
Development of comprehensive PET imaging for precise diagnosis of breast cancer
开发用于乳腺癌精确诊断的综合PET成像
  • 批准号:
    23H02856
  • 财政年份:
    2023
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of internal radiation therapy agents for refractory breast cancer based on phase-shift using focused ultrasound
基于聚焦超声相移的难治性乳腺癌体内放射治疗剂的开发
  • 批准号:
    23H02866
  • 财政年份:
    2023
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The early detection of breast cancer using field cacerization.
使用现场癌症化早期检测乳腺癌。
  • 批准号:
    23K08094
  • 财政年份:
    2023
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of CD44 bearing TJA-II binding glycans in therapy-resistant subset of triple negative breast cancer
携带 CD44 的 TJA-II 结合聚糖在三阴性乳腺癌耐药亚型中的作用
  • 批准号:
    23K06748
  • 财政年份:
    2023
  • 资助金额:
    $ 7.29万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了